Display search results for ** instead (51 products)
30 Jun 2016  |  Global
Immunoglobulin (Ig) therapies are among the oldest therapeutic moieties employed in a broad range of pathological conditions. Immunoglobulin G (IgG) holds the highest share (44%) in the global blood plasma market, with a revenue of $9.24 billion. Currently, the global Ig market is dominated by three major companies, holding about 85% of the total m...
30 Jun 2016  |  Global
The market for regenerative medicine, one of the fastest growing segments in the biotechnology industry, is estimated to reach $67.5 billion by 2020 recording a compound annual growth rate (CAGR) of 22%. Current industry trends signal the expanding horizons of regenerative medicine, with its application being explored in new therapeutic segments su...
31 May 2016  |  Global
Mitigating the Impact of Uncompensated Care
This research service is part of an on-going series of profiles from Frost & Sullivan’s Visionary Healthcare research practice that highlight innovative models for care delivery initiation across the globe. Case studies consider questions such as: What is the impetus for change? What impact could this have? What tools are required to execute? Wha...
01 Apr 2016  |  Global
This edition of the Genetic Alert depicts the current patent landscape and the new life sciences trends across oncolytic virotherapy. Analyst insights on oncolytics viral therapies are also included. The Genetic Alert presents the latest R&D developments and advances with an emphasis on opportunities to profit in the explosive field of genetic tec...
11 Dec 2015  |  Global
Market Due Diligence and Strategy Considerations
The US healthcare industry is undergoing a major transition toward value-based care, affecting all its stakeholders. Centers for Medicare and Medicaid Services (CMS) are steering this transition by developing policies and alternative payment models that affect all reimbursements for healthcare services. This document provides insight into CMS’s 2...
27 Mar 2015  |  Global
Medical and Diagnostic Imaging Technology Alert. Imaging Solution for Early Phase Trials; Vendor Neutral Breast Density Analytic Tool; Nanoparticles f
This issue profiles an imaging solution for early phase trials, a vendor neutral breast density analytic tool, and nanoparticles for multimodality use.
08 Dec 2014  |  Global
Economic Development Innovation: Game Changers in Healthcare
Healthcare delivery and accessibility are critical to the economic development of a country. Using key indicators reflective of the healthcare scenario in a country and comparing them with government expenditure has demonstrated that some countries have improved healthcare conditions despite minimal spending. Innovation in service delivery is key t...
25 Apr 2014  |  Global
Medical and Diagnostic Imaging Technology Alert. Digital Radiography Systems to Increase Imaging Efficiency at Reduced Radiation Dosage; Diagnostic Im
This issue profiles digital radiography systems to increase imaging efficiency at reduced radiation dosage, diagnostic imaging app for all imaging modalities, medical grade X-ray detector from plastic.
17 Dec 2012  |  Global
This segment provides a detailed overview of the fundamentals of Neuropharmacology and the effect of neuropharmaceuticals on cognitive performance of individuals.
20 Nov 2012  |  Global
Healthcare Infrastructure - Decision Support Database focuses on health infrastructure status of different countries across regions. This also has a separate set of parameters pertaining to Health Infrastructure of United States only